Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
10/2005
10/26/2005EP1589019A1 Stereoselective process for the preparation of Clopidogrel
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1224697C Process for preparation of amino alcohols and derivatives thereof
10/26/2005CN1224609C Process for preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties
10/26/2005CN1224374C Novel coupler for use in oxidative hair dyeing
10/20/2005WO2005097731A2 Ionic liquids comprising nitrogen containing cations
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234129 Salts of nateglinide
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005CA2563458A1 The use as solvents of ionic liquids comprising nitrogen containing cations
10/19/2005EP1586553A1 Process for preparing amines
10/19/2005EP1585752A1 Polyene polyketides, processes for their production and their use as a pharmaceutical
10/19/2005EP1585718A1 Method for the production of (r)-salbutamol
10/19/2005CN1684678A Thiomolybdate analogues and uses thereof
10/19/2005CN1683320A Process for preparing 1L(1S)-(1(OH), 2, 4, 5/1, 3)-5-amino-1-hydroxy melhyl-1, 2, 3, 4-cyclohexantetraol
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/18/2005CA2144228C Saturated fluoroalkylamines and their derivatives, and mixtures thereof
10/13/2005US20050228198 Manufacture of phenyl ethylamine compounds, in particular venlafaxine
10/13/2005US20050227993 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
10/13/2005US20050227860 Polymerisation catalyst
10/12/2005EP1584621A1 A process for the preparation of tolterodine and intermediates thereof
10/12/2005EP1201235B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
10/06/2005WO2005092834A1 Processes for the purification of voglibose and intermediates thereof
10/06/2005WO2005092832A1 Method of producing aminophenol compounds
10/06/2005WO2005092011A2 Mitotic kinesin inhibitors
10/06/2005US20050222437 Process for the preparation of tolterodine and intermediates thereof
10/06/2005US20050222430 Decarboxylating an alpha -amino acid under heating in a high boiling liquid polymer having average molecular weight 200 to 6000, and directly recovering said amine by distillation
10/06/2005CA2560213A1 Mitotic kinesin inhibitors
10/05/2005EP1226107B1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
10/05/2005CN1678563A Method for the production of optically active 2-amino-, 2-chloro-, 2-hydroxy or 2-alkoxy-1-alcohols
10/05/2005CN1678562A Method for the enantioselective hydrogenation of amino alcohols
10/05/2005CN1221532C Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses
10/04/2005US6951961 Methods of use and compositions for the diagnosis and treatment of infectious disease
10/04/2005US6951574 Primary intermediates for oxidative coloration of hair
09/2005
09/30/2005CA2502640A1 A process for the preparation of tolterodine and intermediates thereof
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215647 N-methyl-3-hydroxy-4,4-dimethyl-2-(2'naphthyl)pentylamine; potent, wide-spectrum antidepressant and treating anxiety disorders
09/28/2005EP1580185A1 Secondary n-Alkylhydroxylated p-Phenylendiamins, dye composition for keratin fibers containing them, processes and uses.
09/28/2005EP1580184A1 secondary N-alkylepolyhydroxilated p-phenylendiamines, dye composition comprising them, processes and uses
09/28/2005EP1578353A2 Methods of use and compositions for the diagnosis and treatment of infectious disease
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1673211A L-ephedrine hydrochloride isomerizing process of preparing d-pseudoephedrine hydrochloride
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005CA2193337C 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
09/22/2005WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087707A1 Chiral tertiary aminoalkylnaphthols
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005WO2005070870A3 Amino alcohol derivatives and their use as renin inhibitors
09/22/2005US20050209486 (1R, 2S)-2-amino-1-(4-hydroxyphenyl)propan-1-ol) ; used to make agents for prevention or treatment of obesity, hyperglycemia or a disease caused by intestinal tract hypermotility
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005CA2556962A1 Chiral tertiary aminoalkylnaphthols
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1575495A2 Compounds and methods
09/21/2005CN1671651A N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
09/21/2005CN1671650A Crystalline beta2 adrenergic receptor agonist
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1219759C Intermediate for preparing substitated biphenyl oxazoline compounds
09/21/2005CN1219501C Primary intermediates for oxidative coloration of hair
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085189A2 Analogues of congo red and evaluation of their anti-prion activity
09/15/2005WO2005085175A1 Alkoxide compound, raw material for thin film formation and process for producing thin film
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/14/2005EP1574495A1 Adamantane derivatives
09/14/2005EP1574494A1 Adamantane derivative
09/14/2005EP1572622A1 Levalbuterol salt
09/14/2005CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
09/14/2005CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives
09/14/2005CN1668591A Phenol derivatives and method of use thereof
09/14/2005CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/14/2005CN1218930C Process for preparing micropowdered salbutamol sulfate
09/13/2005US6943191 dihydroxy or diketoaromatic compounds; protein kinase inhibitors; antiproliferative activity
09/13/2005US6943184 For therapy of Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff s disease cerebral ageing, of mood disorders, of pain and of tobacco withdrawal
09/13/2005CA2137406C Process for key intermediates for hiv protease inhibitors
09/09/2005WO2005082836A1 Synthesis of severely sterically hindered secondary aminoether alcohols from a ketene and/or carboxylic acid halide and/or carboxylic acid anhydride
09/08/2005US20050197482 for production of polyimides; for complexing with epoxy resin/silicone resin; photosensitivity
09/08/2005US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same
09/08/2005US20050197383 Quaternary ammonium compounds and their use as anti-tussive agents
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005CN1666577A Electronic devices made with electron transport and/or anti-quenching layers
09/07/2005CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions
09/07/2005CN1665801A Anti tubercular drug: compositions and methods
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665773A Process for the preparation of i n /i -monosubstituted beta-amino alcohols
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/07/2005CN1217903C Substituted biphenyl oxazoline
09/06/2005USRE38793 dibenzylation of the amino group of alpha-alanine methyl ester, reduction to the N,N-dibenzylamino alcohol, then oxidation to form aldehyde, reaction with grignard reagent to form an intermediate, deprotecing by catalytic hydrogenation
09/06/2005US6939986 From 1,2-epoxides; useful as inhibitors of viral or bacterial neuraminidases
09/06/2005CA2207027C Process for producing tenside-stabilized colloids of mono- and bimetals of the group viii and ib of the periodic system in the form of precursors for catalysts which are isolable and water soluble at high concentration
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005DE102004007499A1 Verfahren zur Herstellung optisch aktiver Alkohole oder Carbonsäuren A process for producing optically active alcohols or carboxylic acids
09/01/2005DE102004007498A1 Hydrierverfahren zur Herstellung optisch aktiver Alkohole oder Carbonsäuren Hydrogenation process for producing optically active alcohols or carboxylic acids
08/2005
08/31/2005EP1568686A1 n-alkylaminated secondary paraphenylendiamine, which is ortho- and/or meta-substituted, dying composition comprising this paraphenylendiamine, methods based on this composition and uses
08/31/2005EP1568685A1 Aminoadamantane derivatives as therapeutic agents
08/31/2005EP1568355A1 N-alkylhydroxilated secondary paraphenylenediamine which is ortho- and/or meta substituted, composition for dying keratinous fibres comprising this paraphenylenediamine, methods based on this composition and uses.
08/31/2005EP1567484A1 Polyene polyketides, processes for their production and their use as pharmaceuticals
08/31/2005EP1069894B1 Spisulosine compounds having antitumour activity
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 116